Site updated at Wednesday, 22 June 2016

Living with Dementia

Memory Disorders

Clinical Conclusions

Using an evidence-based review of the literature, the Quality Standards Subcommittee of the American Academy of Neurology made three levels of recommendation for clinical practice related to the diagnosis and evaluation of individuals with mild cognitive impairment and dementia (Knopman et al. 2001; Petersen et al. 2001): standards were based on patient management… Clinical Conclusions   

A micro-RNA as a key regulator of learning and Alzheimer’s disease

Proteins are the molecular machines of the cell. They transport materials, cleave products or transmit signals - and for a long time, they have been a main focus of attention in molecular biology research. In the last two decades, however, another class of critically important molecules has emerged: small RNA molecules, including micro-RNAs. It… A micro-RNA as a key regulator of learning and Alzheimer’s disease   

Going Home (A short film on Dementia)

memory losses1 - fish oil supplements1 - pdad1 - hiv infection1 - phosphorylated tau1 - treatment of alzheimer's disease1 - autism spectrum1 - memory decline2 - journal of alzheimer's disease2 - impaired memory1 - socioeconomic boundaries1 - the gerontological society of america1 - carus1 - dementia patients8 - icd-101 - deep brain stimulation2 - amyloid beta 42 peptide1 - atypical antipsychotic drugs1 - alzheimer society1 - ptau1 - risk of developing parkinson's1 - cognitive deterioration2 - sinus issues1 - wernicke's syndrome10 - alzheimer's treatments3 - p-tau1 - decline in memory1 - cognitive functions1 - people with parkinsons1 - mental faculties2 -